The Flare of Rheumatic Disease After SARS-CoV-2 Vaccination: A Review
As the coronavirus disease 2019 (COVID-19) pandemic continues worldwide, vaccination has been considered an effective measure to protect people from the COVID-19 and end the pandemic. However, for patients with rheumatic diseases (RD), concern for the induction of RD flare may combat the enthusiasm...
Main Authors: | Yan Xie, Yang Liu, Yi Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.919979/full |
Similar Items
-
SARS-CoV-2 vaccination in inflammatory bowel disease patients is not associated with flares: a retrospective single-centre Swiss study
by: Laura N. Rossier, et al.
Published: (2024-12-01) -
CVAPPS: A Cross-Sectional Study of SARS-CoV-2 Vaccine Acceptance, Perceptions, and Post-Vaccination Side Effects among Rheumatic Disease Patients in Kuwait
by: Fatemah Baroun, et al.
Published: (2023-03-01) -
Anti-rheumatic in SARS-CoV-2: benefit or risk?
by: Francesco Ferrara
Published: (2020-04-01) -
Epidemiology of Immune-Mediated Glomerulopathies before and after SARS-CoV-2 Vaccination: A Tertiary Referral Hospital Experience
by: Jorge Iván Zamora, et al.
Published: (2023-03-01) -
Comparison of Homologous and Heterologous Booster SARS-CoV-2 Vaccination in Autoimmune Rheumatic and Musculoskeletal Patients
by: Dániel Honfi, et al.
Published: (2022-09-01)